Anti-Cancer Agents in Medicinal Chemistry
Formerly: Current Medicinal Chemistry - Anti-Cancer Agents
Volume 20, 18 Issues, 2020
ISSN: 1875-5992 (Online)
ISSN: 1871-5206 (Print)
This journal supports open access
ISSN: 1875-5992 (Online)
ISSN: 1871-5206 (Print)
This journal supports open access
  |
In the current pandemic scenario, publication process of all articles related to Coronavirus will be expedited, for timely publication of much needed research
Contents
Anti-Cancer Agents in Medicinal Chemistry, Volume 12 - Number 7
Introduction: MMPs, ADAMs/ADAMTSs Research Products to Achieve Big Dream
, 12(7): 688 - 706Isao Okazaki and Kazuki Nabeshima
DOI: 10.2174/187152012802650200
Inhibiting Matrix Metalloproteinases, an Old Story with New Potentials for Cancer Treatment
, 12(7): 707 - 717Dimitris Stellas and Evangelia Patsavoudi
DOI: 10.2174/187152012802650246
Modulation of MMPs by Cell Surface Integrin Receptor α5β1
, 12(7): 726 - 732Sekhar Pal, Kirat Kumar Ganguly, Shuvojit Moulik and Amitava Chatterjee
DOI: 10.2174/187152012802650183
MicroRNAs in Cancer: Small Molecules, Big Chances
, 12(7): 733 - 743Mohammed Abba, Giridhar Mudduluru and Heike Allgayer
DOI: 10.2174/187152012802650273
Differential Expressions of Matrix Metalloproteinases, A Disintegrin and Metalloproteinases, and a Disintegrin and Metalloproteinases with Thrombospondin Motifs and their Endogenous Inhibitors Among Histologic Subtypes of Lung Cancers
, 12(7): 744 - 752Yasuhiro Hida and Jun-ichi Hamada
DOI: 10.2174/187152012802650156
Novel Strategies for Hepatocellular Carcinoma Based on MMPs Science
, 12(7): 753 - 763Isao Okazaki and Yutaka Inagaki
DOI: 10.2174/187152012802650165
MMPs in Ovarian Cancer as Therapeutic Targets
, 12(7): 764 - 772Amer Karam and Oliver Dorigo
DOI: 10.2174/187152012802650174
Regulation of MMPs During Melanoma Progression: From Genetic to Epigenetic
, 12(7): 773 - 782Frank Antonicelli, David Vallerand, Aurélie Trussardi-Regnier, Florent Grange, William Hornebeck and Philippe Bernard
DOI: 10.2174/187152012802650228
The Cytotoxic Effect of Emetine and CGP-74514A Studied with the Hollow Fiber Model and ArrayScan Assay in Neuroendocrine Tumors In Vitro
, 12(7): 783 - 790Dhana E. Larsson, Saadia B. Hassan, Kjell Oberg and Dan Granberg
DOI: 10.2174/187152012802650147
A Novel Fusicoccin Derivative Preferentially Targets Hypoxic Tumor Cells and Inhibits Tumor Growth in Xenografts
, 12(7): 791 - 800Koshi Kawakami, Miho Hattori, Takatsugu Inoue, Yuriko Maruyama, Junko Ohkanda, Nobuo Kato, Miki Tongu, Takaya Yamada, Miho Akimoto, Keizo Takenaga, Takeshi Sassa, Junji Suzumiy and Yoshio Honma
DOI: 10.2174/187152012802650264
Design of N-substituted Amino Caproic Hydroxamic Acid Histone Deacetylase Inhibitors Reveal an Essential Role for Cap Atomic Composition
, 12(7): 801 - 806Jean M. Brunel, Chanaz Salmi-Smail, Audrey Restouin, Thomas Prebet, Norbert Vey and Yves Collette
DOI: 10.2174/187152012802650192
Calculation of Molecular Features with Apparent Impact on Both Activity of Mutagens and Activity of Anticancer Agents
, 12(7): 807 - 817Andrey A. Toropov, Alla P. Toropova, Emilio Benfenati, Giuseppina Gini, Danuta Leszczynska and Jerzy Leszczynski
DOI: 10.2174/187152012802650255
Anticancer Activity of New Haloalkyl Camptothecin Esters against Human Cancer Cell Lines and Human Tumor Xenografts Grown in Nude Mice
, 12(7): 818 - 828Zhisong Cao, John Mendoza, Anthony Kozielski, Xing Liu, Albert DeJesus, Yang Wang, Chang-Guo Zhan, Dana Vardeman and Beppino Giovanella
DOI: 10.2174/187152012802650219
Concurrent Administration of Rituximab and CHOP Chemotherapeutic Agents for Outpatients with CD20-positive Lymphoma
, 12(7): 829 - 834Yoshihiro Yakushijin, Tomiko Tatsukawa, Takumi Yamaguchi, Takashi Egawa, Noriaki Hidaka, Keiko Ido, Katsuya Suemaru, Masaki Yasukawa and Hiroak Araki
DOI: 10.2174/187152012802650138
Editor-in-Chief
Michelle Prudhomme
Institut de Chimie de Clermont-Ferrand
ICCF-CNRS UMR 6296
Université Clermont Auvergne
Clermont-Ferrand
(France)
Biography
View Full Editorial Board
Institut de Chimie de Clermont-Ferrand
ICCF-CNRS UMR 6296
Université Clermont Auvergne
Clermont-Ferrand
Biography
Biography of Michelle Prudhomme
Prof. Michelle Prudhomme holds the position of Emeritus Professor at the Blaise Pascal University of Clermont-Ferrand, France. She was awarded Doctor-Engineer degree at the University of Caen France where her research focused on the synthesis of sulfur compounds. Then she received her Ph.D. Degree at the University of Clermont-Ferrand, France, after works on antibiotics. She developed projects related to drug design and discovery of cytotoxic compounds. She has authored or co-authored 108 research and review articles and and 6 patents.
Dr. Michelle Prudhomme was the founding Editor (2000) and is currently the Editor-in-Chief of this journal (Anti-Cancer Agents in Medicinal Chemistry), published by Bentham Science Publishers.
About the Journal
For Authors
For Librarians & Readers
Quick Links
Journal History
Current Medicinal Chemistry - Anti-Cancer Agents was launched in 2001 and later renamed in 2006 as Anti-Cancer Agents in Medicinal Chemistry.
Scopus CiteScore Metrics: 2.38
Advertisement
Webmaster Contact: info@benthamscience.net